The ZAP-X® system provides a non-invasive, single-session treatment for uveal melanoma, achieving tumor control rates similar ...

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma ...

A new way to deliver cancer medicine directly to the liver may help patients with a rare and aggressive type of eye cancer ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

The rare ocular, acral and mucosal melanoma subtypes have no known environmental risk factors, making early detection and treatment challenging.

Gemma Small, 33, was told a cancer she hoped had been successfully treated had in fact spread to her liver, resulting in a devastating diagnosis that has shattered a young family ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

The Melphalan/Hepatic Delivery System is a drug or medical device combination used for liver-directed treatment of ...

"[Money raised] for uveal melanoma research is a powerful step toward advancing much-needed treatments. While there is still no cure for this rare and aggressive disease, the generosity of this ...

A breakthrough in cancer treatment has emerged from a multi-institutional study led by the Moffitt Cancer Center in Florida, ...